Insulin Human Winthrop Euroopa Liit - eesti - EMA (European Medicines Agency)

insulin human winthrop

sanofi-aventis deutschland gmbh - insulin human - diabeet mellitus - diabeetis kasutatavad ravimid - suhkurtõbi, kus on vaja insuliiniravi. insuliini inimese winthrop kiire sobib ka millega kaasnes hüperglükeemiline kooma ja ketoatsidoos, samuti saavutada enne, intra - ja postoperatiivne stabiilsuse patsientidel, kellel.

Dimethyl fumarate Mylan Euroopa Liit - eesti - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Euroopa Liit - eesti - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Euroopa Liit - eesti - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Euroopa Liit - eesti - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetüülfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosupressandid - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Euroopa Liit - eesti - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetüülfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosupressandid - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

ARDEYHEPAN kaetud tablett Eesti - eesti - Ravimiamet

ardeyhepan kaetud tablett

ardeypharm gmbh - silümariin - kaetud tablett - 105mg 60tk; 105mg 20tk; 105mg 100tk

CARSIL kaetud tablett Eesti - eesti - Ravimiamet

carsil kaetud tablett

sopharma ad - silümariin - kaetud tablett - 22,5mg 80tk

CARSIL kõvakapsel Eesti - eesti - Ravimiamet

carsil kõvakapsel

sopharma ad - silümariin - kõvakapsel - 110mg 30tk

HUMAN ALBUMIN CSL BEHRING infusioonilahus Eesti - eesti - Ravimiamet

human albumin csl behring infusioonilahus

csl behring gmbh - albumiin - infusioonilahus - 200g 1l 50ml 1tk